Aspercreme Arthritis
NDC 41167-0573, Diclofenac Sodium, gel, from Chattem, Inc..
- Product NDC
- 41167-0573
- Status
- Listed
- Labeler
- Chattem, Inc.
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA211253
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/41167-0573 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DICLOFENAC SODIUM.01 g/g
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 41167-0573-2 | 41167057302 | 1 TUBE in 1 CARTON (41167-0573-2) / 50 g in 1 TUBE |
| 41167-0573-3 | 41167057303 | 1 TUBE in 1 CARTON (41167-0573-3) / 100 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 41167-0573 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/41167-0573 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 41167-0573. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.